✦ LIBER ✦

2.267 LONG-TERM EFFICACY OF SAFINAMIDE AS ADD-ON TO LEVODOPA IN PARKINSON'S DISEASE (PD) USING AN ‘ON’ AND ‘ON-OFF’ TREATMENT ANALYSIS

✍ Scribed by R. Anand; R. Borgohain; M. Bhatt; F. Stocchi; D. Chirileanu; V. Lucini

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term efficacy and safety of safinam

✍ A. H. V. Schapira; F. Stocchi; R. Borgohain; M. Onofrj; M. Bhatt; P. Lorenzana; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 548 KB

2.269 SAFINAMIDE AS ADD-ON TO LEVODOPA I

✍ R. Anand; C. Meshram; J. Szasz; M. Bhatt; R. Guiliani; E. Forrest; V. Lucini 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

2.266 TWO-YEAR, PLACEBO-CONTROLLED SAFET

✍ R. Borgohain; J. Szasz; P. Stanzione; R. Guiliani; V. Lucini; ; R. Anand 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

2.209 Long-term double-blind, placebo-co

✍ R. Anand; V. Lucini; R. Guiliani; S. Rossetti 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Long term role of pergolide as an adjunc

✍ J.C. Sharma; I.N. Ross 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Efficacy, safety and tolerability of ras

✍ Isaacson, S.; Silver, D.; Choudhry, A.; Hauser, R.A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 78 KB